Non-Hodgkin's lymphomas, version 1.2013.

Published

Journal Article

These NCCN Guidelines Insights summarize several key updates to the NCCN Guidelines for Non-Hodgkin's Lymphomas (NHL) and provide a discussion of the clinical evidence that support the updates. The updates discussed in this article feature recommendations for additional treatment options in patients with chronic lymphocytic leukemia and guidance surrounding the management of hepatitis virus reactivation/infections in high-risk patients with NHL undergoing antitumor therapy.

Full Text

Duke Authors

Cited Authors

  • Zelenetz, AD; Wierda, WG; Abramson, JS; Advani, RH; Andreadis, CB; Bartlett, N; Bellam, N; Byrd, JC; Czuczman, MS; Fayad, LE; Glenn, MJ; Gockerman, JP; Gordon, LI; Harris, NL; Hoppe, RT; Horwitz, SM; Kelsey, CR; Kim, YH; Krivacic, S; LaCasce, AS; Nademanee, A; Porcu, P; Press, O; Pro, B; Reddy, N; Sokol, L; Swinnen, L; Tsien, C; Vose, JM; Yahalom, J; Zafar, N; Dwyer, MA; Naganuma, M; National Comprehensive Cancer Network,

Published Date

  • March 1, 2013

Published In

Volume / Issue

  • 11 / 3

Start / End Page

  • 257 - 272

PubMed ID

  • 23486452

Pubmed Central ID

  • 23486452

Electronic International Standard Serial Number (EISSN)

  • 1540-1413

Language

  • eng

Conference Location

  • United States